Volatility in the economy is causing digital health companies to rethink their strategies for the remainder of 2025.

We recently published a list of Why These 10 Stocks Soared Today. In this article, we are going to take a look at where ...

Elizabeth Krutoholow; VP, Investor Relations; Tempus AI Inc. Jim Rogers; Chief Financial Officer; Tempus AI Inc. Eric Lefkofsky; Chief Executive Officer, Director; T ...

The biggest strategic highlight for Tempus AI Inc. (NASDAQ: TEM) during the first quarter was a multi-million dollar deal to build "the world's largest foundation model for oncology." ...

Tempus AI Inc (TEM) reports a 75.4% revenue increase and a significant $200 million partnership, setting the stage for a promising fiscal year.

The firm's Genomics revenues increased 89 percent, while Data and Services revenues rose 43 percent year over year.

Lefkofsky announced a three-year, $200 million data and modeling license agreement with AstraZeneca and Pathos to build the world’s largest foundation model in oncology. This agreement increased ...

Tempus AI continued to see dramatic revenue and gross profit growth in the first quarter, with year-over-year revenue up 75.4 ...

Tempus AI (NASDAQ: TEM), a fast-rising player in clinical AI and health data infrastructure, will report its Q1 2025 earnings ...

Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

Dear Eric: My friend fell on hard times and couldn’t afford his condo after retiring and living on Social Security. We are both seniors and friends for a long time. I am financially secure ...

I am a 62-year-old woman who recently relocated to her hometown in the Midwest from the East Coast, after 40 years. I have a wonderful network of friends here, whom I’ve known practically my entire ...